GGHC
ERAS icon

Gilder Gagnon Howe & Co’s Erasca ERAS Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$916K Buy
+56,597
New +$669K 0.01% 221

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Gilder Gagnon Howe & Co's ERAS Position: Q1 2026 in Review

Gilder Gagnon Howe & Co opened a new position in Erasca (ERAS) in Q1 2026: 56,597 shares worth $916K. The stake represents 0.01% of the portfolio and ranks #221 among its holdings.

225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Gilder Gagnon Howe & Co held 56,597 shares of Erasca worth $916K as of Q1 2026.
  • Erasca was a new Gilder Gagnon Howe & Co position in Q1 2026.
  • Erasca made up 0.01% of Gilder Gagnon Howe & Co's portfolio in Q1 2026, its #221 holding.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.